|
gptkbp:instanceOf
|
gptkb:chemical_compound
Hallucinogen
Psychedelic drug
|
|
gptkbp:affects_5-HT2A_receptor
|
true
|
|
gptkbp:affects_adrenergic_receptors
|
true
|
|
gptkbp:affects_dopamine_receptors
|
true
|
|
gptkbp:CASNumber
|
50-37-3
|
|
gptkbp:commonName
|
LSD
|
|
gptkbp:derivedFrom
|
gptkb:Lysergic_acid
|
|
gptkbp:discoveredBy
|
gptkb:Albert_Hofmann
|
|
gptkbp:discoveredIn
|
1938
|
|
gptkbp:effect
|
gptkb:Euphoria
gptkb:Anxiety
gptkb:Synesthesia
gptkb:Hallucinations
gptkb:Paranoia
Altered perception
Increased heart rate
Dilated pupils
|
|
gptkbp:eliminationHalfLife
|
3–5 hours
|
|
gptkbp:firstSynthesized
|
gptkb:Sandoz_Laboratories
|
|
gptkbp:form
|
C20H25N3O
|
|
gptkbp:has_duration_of_action
|
6–12 hours
|
|
gptkbp:has_historical_use_in_1960s_counterculture
|
true
|
|
gptkbp:has_historical_use_in_CIA_MKUltra_program
|
true
|
|
gptkbp:has_risk_of_flashbacks
|
true
|
|
gptkbp:has_risk_of_HPPD
|
true
|
|
gptkbp:has_tolerance
|
Rapidly developing
|
|
gptkbp:hasStreet
|
gptkb:Windowpane
gptkb:Lucy
gptkb:Microdot
gptkb:Blotter
Tabs
|
|
gptkbp:hasUNII
|
DZM13O6Y6P
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lysergsäurediethylamid
|
|
gptkbp:is_a_serotonin_receptor_agonist
|
true
|
|
gptkbp:is_colorless
|
true
|
|
gptkbp:is_controlled_substance
|
true
|
|
gptkbp:is_illegal_in_most_countries
|
true
|
|
gptkbp:is_not_considered_addictive
|
true
|
|
gptkbp:is_not_physically_addictive
|
true
|
|
gptkbp:is_odorless
|
true
|
|
gptkbp:is_sensitive_to_air
|
true
|
|
gptkbp:is_sensitive_to_chlorine
|
true
|
|
gptkbp:is_sensitive_to_light
|
true
|
|
gptkbp:is_subject_of_research_for_addiction
|
true
|
|
gptkbp:is_subject_of_research_for_anxiety
|
true
|
|
gptkbp:is_subject_of_research_for_depression
|
true
|
|
gptkbp:is_subject_of_research_for_PTSD
|
true
|
|
gptkbp:is_tasteless
|
true
|
|
gptkbp:is_used_in_microdosing
|
true
|
|
gptkbp:is_used_recreationally
|
true
|
|
gptkbp:IUPACName
|
(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
|
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
Schedule 9 (Australia)
Anlage I (Germany)
|
|
gptkbp:mass
|
323.43 g/mol
|
|
gptkbp:meltingPoint
|
83 °C
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL98
5761
5555
|
|
gptkbp:routeOfAdministration
|
gptkb:Oral
Intravenous
Sublingual
|
|
gptkbp:studiedBy
|
true
|
|
gptkbp:synonym
|
gptkb:Acid
Delysid
|
|
gptkbp:used_in_psychotherapy
|
true
|
|
gptkbp:bfsParent
|
gptkb:LSD-25
|
|
gptkbp:bfsLayer
|
7
|